R&D OF AN INVESTIGATIONAL NEW DRUG (IND) SPONSOR, COMPLIANT CLINICAL TRIALS LEADING TO A NEW INDICATION FOR…
Award details are derived from public USAspending.gov records. Not a bid recommendation.
Award details
- Award ID
- W81XWH20C0122
- Contractor
- Awarding agency
- Department of Defense
- Sub-agency / office
- Department of the Army
- Award amount
- $3,742,408
- Period of performance
- Sep 25, 2020 – Sep 24, 2023
- NAICS
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- PSC AD22
- Place of performance
- MD
Public award description
R&D OF AN INVESTIGATIONAL NEW DRUG (IND) SPONSOR, COMPLIANT CLINICAL TRIALS LEADING TO A NEW INDICATION FOR VALPROIC ACID (VPA) FOR TREATMENT OF PATIENTS WITH SIGNIFICANT HEMORRHAGE, NAVAL MEDICAL RESEARCH CENTER
Find out who's winning similar federal contracts
Discover comparable awards, related contractors, and agency purchasing history.